New Brunswick Scientific Co., Inc., Launches New Slim Styled Space-Saving Innova -86 Degrees Celsius Freezer

EDISON, N.J., Oct. 17  /PRNewswire-FirstCall/ -- New Brunswick Scientific Co., Inc. (NBS) (NASDAQ:NBSC), today announced the roll-out of its Innova(R) U360 ultra-low temperature freezer, the latest in the range of 10 available models.  Designed for long-term storage of culture and tissue samples, the new -86 degrees Celsius, 12.7 cu. ft. capacity Innova U360 boasts an advanced new user interface with data logging capability incorporated in a slimmed-down design.  This design provides a better solution for the problem of sample storage in research and development laboratories where space is at a premium.

New Brunswick Scientific President and Chief Operating Officer James Orcutt explained, "Our vacuum-insulation panels reduce wall thickness, thereby maintaining a small footprint while increasing interior storage capacity. At only 26.4 inches wide including the handle the U360 fits where conventional uprights cannot, and adds new low-noise technology, superior energy efficiency and a brilliant new display with intelligent on-screen messaging and diagnostics. The system automatically logs up to 30 days of temperature, alarm and door-opening data for on-screen graphing and downloading. Programmable alarms that interface with building management systems provide total sample security.

"Today's announcement represents another in a growing list of accomplishments owing their realization to a sustained commitment to improving and diversifying NBS' product line via strategic investment in R&D. This strategy continues to produce a pipeline of innovative new products and enhancements to help drive sales in 2006 and beyond," Orcutt concluded.

To be added to New Brunswick Scientific's e-mail distribution list, please click on the link below:

  http://www.clearperspectivegroup.com/clearsite/nbsc/emailoptin.html

  About New Brunswick Scientific


New Brunswick Scientific Co., Inc., is a leading global provider of a comprehensive line of research equipment and scientific instrumentation for use in the life science industry. The Company's products are used in the creation, maintenance and control of physical and biochemical environments required for the growth, detection and storage of microorganisms for medical, biological and chemical applications, as well as environmental research and commercial product development. NBS is a forerunner in the research and development of pioneering equipment to meet the challenges of new areas of advancement in life science. Established in 1946, New Brunswick Scientific is headquartered in Edison, New Jersey, with sales and distribution facilities strategically located in the United States, Europe and Asia. For more information, please visit http://www.nbsc.com/ .

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.  Forward- looking statements may be identified by words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "will" or words of similar meaning and include, but are not limited to, statements about the expected future business and financial performance of the Company. The forward-looking statements involve a number of risks and uncertainties, including but not limited to, changes in economic conditions, demand for the Company's products, pricing pressures, intense competition in the industries in which the Company operates, the need for the Company to keep pace with technological developments and respond in a timely manner to changes in customer needs, the Company's dependence on third-party suppliers, the effect on foreign sales of currency fluctuations, acceptance of new products, the labor relations of the Company and its customers and other factors identified in the Company's Securities and Exchange Commission filings. Forward-looking statements are based on management's current expectations and assumptions, which are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. Actual outcomes and results may differ materially from these expectations and assumptions due to changes in global political, economic, business, competitive, market, regulatory and other factors. The Company undertakes no obligation to publicly update or review any forward-looking information, whether as a result of new information, future developments or otherwise. 

DATASOURCE: New Brunswick Scientific Co., Inc.



CONTACT:  Samuel Eichenbaum, Vice President, Finance and Treasurer of New

Brunswick Scientific Co., Inc., [phone], ; or Matthew J.

Dennis, CFA, NBS Investor Relations, of Clear Perspective Group, LLC for New

Brunswick Scientific Co., Inc., [phone], 



Web site:  http://www.nbsc.com/ 

Copyright